{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:03:29Z","timestamp":1790359409865,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Evidence to guide hemodialysis catheter locking solutions is limited. We aimed to assess effectiveness and cost of recombinant tissue plasminogen activator (rt-PA) once per week as a locking solution, compared with thrice weekly citrate or heparin, in patients at high risk of complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>We used a prospective design and pre-post comparison in three sites across Canada. Pre-post comparisons were conducted using multilevel mixed effects regression models accounting for cluster with site and potential enrollment of patients more than once. In the pre period, catheter malfunction was managed as per site-specific standard of care. The intervention in the post period was once weekly rt-PA as a locking solution (with citrate or heparin used for other sessions). The primary outcome was rate of rt-PA use for treatment of catheter malfunction. Secondary outcomes included rates of bacteremia, management of catheter malfunction, and cost.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 374 patients (mean age 68 years; 52% men) corresponding to 506 enrollments. Mean length of enrollment was 200 days (SD 119) in the pre period and 187 days (SD 101) in the post period. There was a significant decline in rate of rt-PA use for treatment of catheter malfunction in the post compared with pre period (adjusted incidence rate ratio, 0.39; 95% confidence interval, 0.30 to 0.52); however, there was no difference in the rate of bacteremia, or catheter stripping or removal\/replacement. The increase in mean total health care cost in the post period was CAD$962 per enrollment, largely related to costs of rt-PA as a locking solution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Once weekly rt-PA as a catheter locking solution was associated with a reduction in rt-PA use for treatment of catheter malfunction. Our results showing a reduction in rescue rt-PA use are consistent with a prior randomized trial, although we did not observe a reduction in bacteremia or catheter stripping\/removal and did observe an increased incremental cost of this strategy primarily accounted for by the cost of the rt-PA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.08510817","type":"journal-article","created":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T20:20:21Z","timestamp":1516047621000},"page":"429-435","source":"Crossref","is-referenced-by-count":12,"title":["Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution"],"prefix":"10.2215","volume":"13","author":[{"given":"Brenda R.","family":"Hemmelgarn","sequence":"first","affiliation":[{"name":"Department of Community Health Sciences and"},{"name":"Division of Nephrology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braden J.","family":"Manns","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences and"},{"name":"Division of Nephrology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Soroka","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeera","family":"Levin","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"MacRae","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Tennankore","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Anne S.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, and"},{"name":"Faculty of Health, College of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Weaver","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6973-8570","authenticated-orcid":false,"given":"Pietro","family":"Ravani","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences and"},{"name":"Division of Nephrology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Quinn","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences and"},{"name":"Division of Nephrology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Tonelli","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences and"},{"name":"Division of Nephrology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedeh","family":"Kiaii","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Mossop","sequence":"additional","affiliation":[{"name":"Nova Scotia Health Authority, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nairne","family":"Scott-Douglas","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,1,15]]},"reference":[{"key":"B2-20230813","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.2215\/CJN.01240308","article-title":"Increased hemodialysis catheter use in Canada and associated mortality risk: Data from the Canadian organ replacement registry 2001-2004.","volume":"3","author":"Moist","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1525-1594.2005.29067.x","article-title":"Survival and complications of indwelling venous catheters for permanent use in hemodialysis patients.","volume":"29","author":"Develter","year":"2005","journal-title":"Artif Organs"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1093\/ndt\/16.11.2194","article-title":"A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters.","volume":"16","author":"Little","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1681\/ASN.2012121234","article-title":"Temporal risk profile for infectious and noninfectious complications of hemodialysis access.","volume":"24","author":"Ravani","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.ajkd.2012.09.006","article-title":"Hemodialysis access usage patterns in the incident dialysis year and associated catheter-related complications.","volume":"61","author":"Xue","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1681\/ASN.V491719","article-title":"Successful use of cuffed central venous hemodialysis catheters inserted percutaneously.","volume":"4","author":"Swartz","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1148\/radiology.203.2.9114110","article-title":"Outcome of tunneled hemodialysis catheters placed via the right internal jugular vein by interventional radiologists.","volume":"203","author":"Trerotola","year":"1997","journal-title":"Radiology"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/ki.2010.471","article-title":"Prevention and management of catheter-related infection in hemodialysis patients.","volume":"79","author":"Lok","year":"2011","journal-title":"Kidney Int"},{"key":"B12-20230813","first-page":"CD009631","article-title":"Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease.","volume":"4","author":"Wang","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMoa1011376","article-title":"Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator.","volume":"364","author":"Hemmelgarn","year":"2011","journal-title":"N Engl J Med"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2054-3581-1-15","article-title":"Risk factors associated with hemodialysis central venous catheter malfunction; A retrospective analysis of a randomized controlled trial.","volume":"1","author":"Ward","year":"2014","journal-title":"Can J Kidney Health Dis"},{"issue":"Suppl 8","key":"B15-20230813","first-page":"i","article-title":"Preventing infections associated with indwelling intravascular access devices.","volume":"23","year":"1997","journal-title":"Can Commun Dis Rep"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1681\/ASN.2013050463","article-title":"An economic evaluation of rt-PA locking solution in dialysis catheters.","volume":"25","author":"Manns","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P","article-title":"Analysis of cost data in randomized trials: An application of the non-parametric bootstrap.","volume":"19","author":"Barber","year":"2000","journal-title":"Stat Med"},{"key":"B18-20230813","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00019053-199813050-00002","article-title":"The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data.","volume":"13","author":"Desgagn\u00e9","year":"1998","journal-title":"Pharmacoeconomics"},{"key":"B19-20230813","first-page":"312","article-title":"Bootstrap methods and their application: Some bootstrapping techniques.","volume":"4","author":"Davison","year":"2004","journal-title":"Stata J"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2753.2006.00711.x","article-title":"New models for old questions: Generalized linear models for cost prediction.","volume":"13","author":"Moran","year":"2007","journal-title":"J Eval Clin Pract"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1523-1755.2003.00064.x","article-title":"Nonadherence in hemodialysis: Associations with mortality, hospitalization, and practice patterns in the DOPPS.","volume":"64","author":"Saran","year":"2003","journal-title":"Kidney Int"},{"key":"B22-20230813","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5301\/jva.5000560","article-title":"Hemodialysis patients\u2019 satisfaction and perspectives on complications associated with vascular access related interventions: Are we listening?","volume":"17","author":"Kosa","year":"2016","journal-title":"J Vasc Access"},{"key":"B23-20230813","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1053\/j.ajkd.2010.10.053","article-title":"Morphometric and biological characterization of biofilm in tunneled hemodialysis catheters.","volume":"57","author":"Jones","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"B24-20230813","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/jac\/dkp060","article-title":"Effect of a solution containing citrate\/methylene blue\/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions.","volume":"63","author":"Sauer","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"B25-20230813","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/ndt\/gfl170","article-title":"Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces.","volume":"21","author":"Shanks","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"B26-20230813","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1525-139X.2008.00497.x","article-title":"Infection associated with tunneled hemodialysis catheters.","volume":"21","author":"Beathard","year":"2008","journal-title":"Semin Dial"},{"key":"B27-20230813","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/ajkd.2002.34924","article-title":"Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access.","volume":"40","author":"Lee","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1681\/ASN.2004050355","article-title":"Establishment and maintenance of vascular access in incident hemodialysis patients: A prospective cost analysis.","volume":"16","author":"Manns","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B29-20230813","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/j.ajkd.2013.08.016","article-title":"Citrate versus heparin lock for hemodialysis catheters: A systematic review and meta-analysis of randomized controlled trials.","volume":"63","author":"Zhao","year":"2014","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201803000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:37:01Z","timestamp":1786369021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201803000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,15]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.08510817","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,15]]}}}